The next head of the U.S. Food and Drug Administration will find a plate full of important legal and regulatory issues, and not just for lawyers engaged in basic food, drug and health law.
Also on the front burner for the successor to FDA Commissioner Margaret Hamburg, who announced Feb. 5 that she would step down next month, will be patent, intellectual property and information-technology matters. Such is the reach of an agency considered the broadest and most powerful regulatory body in the world.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
